- Home
- ATXS vs SCHL Comparison
ATXS vs SCHL Comparison
Compare ATXS & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- SCHL
- Stock Information
- Founded
- ATXS 2008
- SCHL 1920
- Country
- ATXS United States
- SCHL United States
- Employees
- ATXS N/A
- SCHL N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- SCHL Books
- Sector
- ATXS Health Care
- SCHL Consumer Discretionary
- Exchange
- ATXS Nasdaq
- SCHL Nasdaq
- Market Cap
- ATXS 401.2M
- SCHL 478.8M
- IPO Year
- ATXS 2015
- SCHL 1987
- Fundamental
- Price
- ATXS $5.86
- SCHL $19.12
- Analyst Decision
- ATXS Strong Buy
- SCHL
- Analyst Count
- ATXS 7
- SCHL 0
- Target Price
- ATXS $32.43
- SCHL N/A
- AVG Volume (30 Days)
- ATXS 479.1K
- SCHL 260.9K
- Earning Date
- ATXS 08-11-2025
- SCHL 07-17-2025
- Dividend Yield
- ATXS N/A
- SCHL 4.18%
- EPS Growth
- ATXS N/A
- SCHL N/A
- EPS
- ATXS N/A
- SCHL 0.65
- Revenue
- ATXS N/A
- SCHL $1,592,100,000.00
- Revenue This Year
- ATXS N/A
- SCHL $3.42
- Revenue Next Year
- ATXS N/A
- SCHL $5.47
- P/E Ratio
- ATXS N/A
- SCHL $29.33
- Revenue Growth
- ATXS N/A
- SCHL N/A
- 52 Week Low
- ATXS $3.56
- SCHL $15.77
- 52 Week High
- ATXS $12.92
- SCHL $38.77
- Technical
- Relative Strength Index (RSI)
- ATXS 62.16
- SCHL 58.16
- Support Level
- ATXS $5.43
- SCHL $18.45
- Resistance Level
- ATXS $5.97
- SCHL $19.25
- Average True Range (ATR)
- ATXS 0.44
- SCHL 0.66
- MACD
- ATXS 0.06
- SCHL 0.11
- Stochastic Oscillator
- ATXS 82.37
- SCHL 81.77
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.